{
    "clinical_study": {
        "@rank": "52098", 
        "arm_group": [
            {
                "arm_group_label": ": Ginkgo biloba & methylprednisolone", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients receive Ginkgo biloba & methylprednisolone per oral."
            }, 
            {
                "arm_group_label": "Ginkgo biloba", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients receive Ginkgo biloba per oral."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study was to compare the treatment effectiveness of steroid therapy for\n      vestibular neuritis by using video head impulse test."
        }, 
        "brief_title": "The Efficacy of Steroid Therapy in Vestibular Neuritis", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Vestibular Neuritis", 
        "condition_browse": {
            "mesh_term": [
                "Neuritis", 
                "Vestibular Neuronitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study was a prospective, randomized controlled study. The enrolled vestibular neuritis\n      patients were randomized to conservative treatment or steroid treatment when they are\n      diagnosed with caloric test. After initial vestibular work-up including caloric, video head\n      impulse tests, and a questinnaire (DHI), the patient was examined with the same tests again\n      at 6 months later. The efficacy of steroid for the patients with vestibular neuritis would\n      be determined by the comparison of the data of each group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ages over 18 years\n\n          -  Acute vertigo that occurred within 7 days\n\n          -  The spontaneous nystagmus should be detected\n\n          -  Caloric weakness over 20%\n\n        Exclusion Criteria:\n\n          -  Suspicious or verified a central nervous system lesion\n\n          -  If the patient has denied.\n\n          -  Other otologic disease (acute/chronic otitis media, otosclerosis, etc)\n\n          -  The patient with history of otologic surgery\n\n          -  The patient with history of brain surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02098330", 
            "org_study_id": "SVNHIT_kr"
        }, 
        "intervention": [
            {
                "arm_group_label": ": Ginkgo biloba & methylprednisolone", 
                "description": "Ginkgo biloba 160 mg/day (per oral, 80 mg twice a day) for 1 month. Methylprednisolone 48 mg/day(per oral, once a day for first 9 days. And then methylprednisolone tapering was started every 2 days. The entire duration of methylprednisolone treatment was 14 days.", 
                "intervention_name": "Ginkgo biloba & Methylprednisolone", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Ginexin", 
                    "Methylprednisolone"
                ]
            }, 
            {
                "arm_group_label": "Ginkgo biloba", 
                "description": "Ginkgo biloba 160 mg/day (per oral, 80 mg twice a day) for 1 month.", 
                "intervention_name": "Ginkgo biloba", 
                "intervention_type": "Drug", 
                "other_name": "Ginexin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vestibular neuritis", 
            "Vertigo", 
            "Head impulse test", 
            "Steroid"
        ], 
        "lastchanged_date": "March 28, 2014", 
        "location": {
            "contact": {
                "email": "dzness@amc.seoul.kr", 
                "last_name": "Hong Ju Park, Professor", 
                "phone": "82-2-3010-3700"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "state": "Songpa-gu", 
                    "zip": "138-736"
                }, 
                "name": "Asan Medical Center"
            }, 
            "investigator": {
                "last_name": "Hong Ju Park, Professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy of Steroid Therapy in Vestibular Neuritis Confirmed by Head Impulse Test: Prospective Randomized Controlled Study", 
        "overall_contact": {
            "email": "dzness@amc.seoul.kr", 
            "last_name": "Hong Ju Park, Professor", 
            "phone": "82-2-3010-3700"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Hong Ju Park, Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The effectiveness of steroid therapy was determined by comparing the improvement of vestibular function (the degree of canal paresis by caloric test; gain and presence of refixation-saccade by video HIT test).", 
            "measure": "The improvement in vestibular function test (caloric & videop HIT) after treatment", 
            "safety_issue": "No", 
            "time_frame": "The first results were collected at initial diagnosis. And following results were collected 6 months after the first exam."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02098330"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Hong Ju Park", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The effectiveness of steroid therapy was determined by comparing improvement of subjective symptoms (symptom score by DHI) in each group.", 
            "measure": "The improvement in dizziness handicap inventory after treatment", 
            "safety_issue": "No", 
            "time_frame": "The first results were collected at initial diagnosis. And following results were collected 6 months after the first exam."
        }, 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}